[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Blue Prism Group Plc LSE:PRSM London Ordinary Share GB00BYQ0HV16 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -14.00 -1.18% 1,169.00 152,311 12:02:02
Bid Price Offer Price High Price Low Price Open Price
1,166.00 1,169.00 1,182.00 1,158.00 1,158.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 141.40 -81.40 -92.95 1,117
Last Trade Time Trade Type Trade Size Trade Price Currency
12:00:17 AT 85 1,169.00 GBX

Blue Prism (PRSM) Latest News (4)

More Blue Prism News
Blue Prism Investors    Blue Prism Takeover Rumours

Blue Prism (PRSM) Discussions and Chat

Blue Prism Forums and Chat

Date Time Title Posts
17/9/202111:00Die Roboter8,036
31/8/202115:43 Blue Prism (AIM: PRSM) The robots are coming17
04/8/202110:48Will Blue Prism go to TWENTY POUNDS94
26/6/202020:02Blue Prism active at US banks10
07/11/201911:46Blue Prism prospects for 2019 7

Add a New Thread

Blue Prism (PRSM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:00:171,169.0085993.65AT
11:00:171,169.0041479.29AT
11:00:171,169.002002,338.00AT
11:00:041,168.002012,347.68AT
11:00:041,168.001571,833.76AT
View all Blue Prism trades in real-time

Blue Prism (PRSM) Top Chat Posts

DateSubject
17/9/2021
09:20
Blue Prism Daily Update: Blue Prism Group Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker PRSM. The last closing price for Blue Prism was 1,183p.
Blue Prism Group Plc has a 4 week average price of 804.50p and a 12 week average price of 747.50p.
The 1 year high share price is 1,900p while the 1 year low share price is currently 747.50p.
There are currently 95,546,698 shares in issue and the average daily traded volume is 797,758 shares. The market capitalisation of Blue Prism Group Plc is £1,116,940,899.62.
17/9/2021
04:36
5shar: MSFT has a mkt cap of $2.3trillion and Hugh reserves of cash they already are leaders in software technologies and easily can invest $1billion for R/D on there own the bog 3 have no chance or hope to take on MSFT in the next few yrs has they are just entering this sector..personally I think UIPATH should take both PRSM and Automation both can be taken for $7billion better to pay that and become a giant than slowly but surely gradually lose mkt share and share price would very quickly unravel leaving it worth about $5billion but acquisition of AUTO and PRSM would take it towards $50billion with outlook looking bright and being a huge company only way to stay relevant long term in this sector
17/9/2021
04:23
5shar: If major investors in UIPATH knew that PRSM has NHS Telefonica many financial institutions eBay DWP just some of there clients especially with MSFT sniffing around and their war chest it would be a stupid decision not to take PRSM and their technologies for a 1/10th of UIPATH mkt cap it would also give UIPATH more money for R/D increasing size of company huge client base whilst new clients could have more options has to what suits their needs without this only a matter of time before MSFT with huge cash flow could invest in R_D and be unstoppable this gives UIPATH a chance of remaining a force due to competition rules and grows particularly important are UK clients NHS DWP EBAY and they hv Amazon etc together they can be a major force event if they pay 3000 per share the value of UIPATH would increase very quickly has it gives security that with PRSM takeover they hv become very big and have lots of different packages 2 offer MKT cap would increase far more than what they would pay and very quickly despite UIPATH being far larger in MKT CAP than PRSM there products are not has good for most so it makes perfect sense to take PRSM..If they don't no doubt they will kick themselves going forward
02/9/2021
19:55
hazl: Coast Capital believes Blue Prism is currently undervalued and it would be a mistake to agree to a takeover at the share price. “As you are well aware, the Enterprise Value of Blue Prism PLC is currently valued at approximately three times forward revenues - an 80% to 90% discount to the company’s peers including UiPath, Appian, WorkFusion, Automation Anywhere, etc.,” the letter from Coast Capital said. “Were a buyer to pay a premium of 100%, the share price would still be materially lower than its intrinsic value, and well below where the shares were trading as recently as January 2021.”
01/9/2021
08:29
mcmather: Fag packet speculation Uipath has apprx 3 x earnings of PRSM. Uipath m/c is apprx $32bn / £23.4bn. £23.4bn / 3 = £7.8bn. PRSM isn’t Uipath so say £7.8bn / 2 = £3.9bn. £3.9bn / 96.79m = £40 per share. Present share price £11.
31/8/2021
16:17
cocker: I joined the party albeit only a 1000 shares on 25th June 2021 (post7639) & for what its worth, believe todays rns by PRSM was to make sure the company is not going to be taken out for peanuts. It also allows for others to join the party if they wish, thus share price action could be interesting.
15/7/2021
17:19
dannyboylife: All things being equal, PRSM would be under priced but by ignoring the massive number of serious competitors and price erosion of this market is the biggest mistake. The Followers of PRSM who have taken the time to understand the threats to all RPA vendors in this space are worried for good reason. The last 6 acquirers of RPA technology spent less than 1/10th of PRSM current market cap - and validated by leaping ahead in recent Forrester and Gartner reports, that PRSM management were once touting as First Mover advantage - now wasted.
15/7/2021
13:11
ipsissimosity: Shares in robotic process automation technology company Blue Prism (PRSM:AIM) have fallen to their lowest level in four years, creating a great opportunity to buy this fascinating UK growth story. UK investors are not blessed with lots of fast-growing technology businesses of scale and have often had to look to overseas markets such as the US. But Shares strongly believes Warrington-based Blue Prism is very much a ‘built in Britain’ tech growth story with enormous potential. Blue Prism is a virtual workforce disruptor which uses robotic process automation technology to automate manual back-office administration tasks. This cuts costs for clients, frees the human workforce to do more value-added tasks, increases efficiency, improves customer service and speed, reduces the need for clients to invest in new IT systems and frequently beats customers’ own return on investment hopes, all from a compliance-friendly platform. This is a nascent, fast moving digital industry whose scope to benefit organisations is capturing the imagination of top management teams everywhere and is also pulling in serious money from investors around the world. Some serious customers trust Blue Prism to transform the future of how they run their businesses, with the likes of Ebay, Siemens, the NHS, Fidelity, the UK’s Financial Conduct Authority and Telefonica among more than 2,000 clients. WHY HAS THE SHARE PRICE FALLEN? It wasn’t so very long ago (2018) that the stock traded at over £25 for a market value greater than £2.5 billion. Unfortunately, lower than expected growth, execution issues and the fears of intensifying competition have dragged the shares to their current lows. In April the company said that annual recurring revenue was approximately £168 million, versus £154 million at the end of October 2020. This means revenues are likely to be towards the lower end of the £170 million to £180 million range previously guided for the full year to 31 October 2021. Guidance remained unchanged for losses, which are still expected to come in at around £25 million this year. SO WHY BUY THE SHARES NOW? Management sees improvements to its internal team leadership and improving upsell/cross-sell opportunities in the installed base as ways to put growth back on track. At the half-year results in June, it said the net revenue retention rate was 115%, down on pre-pandemic levels of 143%. This measures the net growth in monthly recurring revenues from customers. Analysts are starting to wonder if competition is beginning to hurt Blue Prism’s growth. Privately-owned Automation Anywhere and UiPath, which listed on Wall Street in April, are the big specialist peers in the market, but Microsoft and others are starting to move into the space, and you can see why given the enormous growth predicted by market researchers for robotic process automation. The sector was estimated to be worth around $1.9 billion in 2019 but a report earlier this year by Global Market Insights predicted it to surge beyond $23 billion by 2026. Combine that opportunity with Blue Prism’s installed base of recurring revenue customers and the huge valuation gap that has opened between the UK company and its main rivals, and you could see how a deep-pocketed potential new entrant might look to acquire Blue Prism to get a headstart in the sector. ‘Blue Prism is trading at circa 5.1-times forward looking enterprise value to sales, which compares to a 39.9 multiple for US peer UiPath,’ pointed out Megabuyte analyst Cameron Naylor in May. A RIPE-LOOKING TAKEOVER TARGET It’s interesting that one of Blue Prism’s biggest sceptics has changed tack and is now telling clients to buy the stock. Analysts at broker Canaccord Genuity sent a note to clients on 27 May entitled ‘Time to buy?’ in which they noted that the stock’s year to 31 October 2021 4.5 times enterprise value to revenue multiple is now ‘substantially below the UK IT sector average’ of 5.5-times, while ‘forecast sales growth is materially above’. This was a major change for the broker since the start of the year when Canaccord was a firm hater of the stock due to what the analysts saw as ‘disappointing’ 2021 guidance. Canaccord’s U-turn now means that not one of the 10 analysts that cover the stock, according to Refinitiv data, now has a sell recommendation, with seven buyers versus a trio of fence-sitting holders. Their average 12-month target price for the shares is £15, implying that the stock has scope to nearly double. Blue Prism should be considered as a higher risk investment given recent setbacks and growing competition. But any patient investor who understands those risks could do well from buying now while sentiment is weak towards the stock. After all, takeovers often happen when people least expect it.
22/6/2021
08:07
fuji99: Danny - I did not consider a takeover. I just compared UiPath market cap and its share price to PRSM's. PRMS share price should be at least more than £50. Also what's your actual interest in BP ?
04/5/2021
11:53
danschmeidler: £72m sales (2% growth) < £9 share price £78m sales (11% growth) = £10 share price £84m sales (20% growth) = £13 share price £90m sales (28% growth) = £16 share price as bargain prices
04/5/2021
11:40
mccore: Agreed Danschmeidler. Without a US listing, this is what I would expect in the following H1 sales scenarios: £72m sales (2% growth) = £9 share price £78m sales (11% growth) = £12 share price £84m sales (20% growth) = £15 share price £90m sales (28% growth) = £18 share price
Blue Prism share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
PRSM
Blue Prism
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210917 11:20:39